Wednesday, February 10, 2010, 7:13am EST - Canadian Markets open in 2 hours and 17 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

ICAgen Inc. (ICGN)

 On Feb 9: 0.76 USD   0.00 (0.00%)  
MORE ON ICGN
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Icagen, Inc. (NGM:ICGN) Delayed quote dataEdit
Last Trade: 0.76 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 0.76
Open: N/A
Bid: 0.10 x 500
Ask: N/A
1y Target Est: 4.00
Day's Range: N/A - N/A
52wk Range: 0.31 - 1.59
Volume: 0
Avg Vol (3m): 168,452
Market Cap: 35.86M
P/E (ttm): N/A
EPS (ttm): -0.41
Div & Yield: N/A (N/A%)
ICAgen Inc. (ICGN)
1d  5d  3m  6m  1y  2y  5y  max 
 Add ICGN to Portfolio   Download Data

HEADLINES
• Stocks Priced Below Net Cash
at Seeking Alpha (Thu, Jan 14)
• ICAGEN INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements
EDGAR Online (Fri, Dec 11)
• Former Glaxo CEO Charles Sanders joins BioCryst board
at bizjournals.com (Wed, Dec 9)
• Icagen gets 180 days to regain Nasdaq compliance
AP (Fri, Nov 13)
• ICAGEN INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf
EDGAR Online (Fri, Nov 13)
• ICAGEN INC Financials
EDGAR Online Financials (Fri, Nov 13)
• ICAGEN INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
• Icagen Inc Earnings Call scheduled for 10:00 am ET today
CCBN (Thu, Nov 5)
• ICAGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
• ICAGEN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Mon, Oct 26)
• Early Movers: Pump Up the Volume
at TheStreet.com (Tue, Oct 20)
More Headlines for ICGN...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 2.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Icagen, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally-administered small molecule drugs that modulate ion channel targets.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices